ProAssurance Q4 net income rises 106% yr/yr

ProAssurance

23/02/2026 21:25

Overview

Specialty insurer's Q4 net income was $33.4 mln

Consolidated net premiums written for 2025 were $916.9 mln

Company merger with The Doctors Company expected to close by mid-2026

Outlook

ProAssurance anticipates closing merger with The Doctors Company by June 30, 2026

Regulatory approval for merger pending in California and Pennsylvania

Result Drivers

RENEWAL PREMIUM INCREASES - Specialty P&C renewal premiums rose 8% in 2025, contributing to a cumulative premium change of over 80% since 2018

INCREASED INVESTMENT INCOME - Net investment income increased 8.3% for the year, driven by higher average book yields

Company press release: ID:nBw9jn1sJa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Gross Premiums
$201.52 mln
Q4 Net Income
$33.37 mln
Q4 Adjusted Operating Income
Beat
$42.39 mln
$9.13 mln (1 Analyst)
Q4 Operating Expenses
$84.89 mln
Q4 Pretax Profit
$46.60 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 3 "hold" and 1 "sell" or "strong sell"

The average consensus recommendation for the property & casualty insurance peer group is "buy."

Wall Street's median 12-month price target for ProAssurance Corp is $25.00, about 2% above its February 20 closing price of $24.50

The stock recently traded at 22 times the next 12-month earnings vs. a P/E of 22 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)